Overview:
A9 Biopharma offers lipids and cholesterol derivatives essential for lipid nanoparticle (LNP) platforms, supporting mRNA, siRNA, and DNA therapeutics. Our controlled synthesis ensures purity, reproducibility, and formulation consistency for all stages of development.

Capabilities:

• Ionizable lipids, PEG-lipids, helper lipids, and cholesterol analogues
• Scale-up from preclinical to clinical supply
• Controlled conditions ensuring uniformity and batch-to-batch consistency

Benefits:

• Robust support for LNP-based therapeutics
• Reliable and scalable solutions for nucleic acid delivery
• Optimized purity and performance for advanced formulations